Answers are grounded in this paper and cite their sources.
The emergence of an oral inflammatory response in COVID-19 highlights the need for monitoring mucosal immunity. This study evaluated pro- and anti-inflammatory salivary cytokine profiles in positive and convalescent patients. Seventy samples were analyzed across four groups: negative control, COVID-19-positive, and two convalescent stages (<1 and >3 months post-infection). Concentrations were quantified via cytometric bead array (CBA) and flow cytometry. Statistical analyses revealed significant alterations, with the acute group exhibiting elevated Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-10 (IL-10). Furthermore, correlation analyses identified distinct inflammatory signatures across clinical stages, including a robust association between late IL-10 levels and initial disease severity. These findings demonstrate that COVID-19 induces significant shifts in the oral immune response that persist into convalescence. This study establishes salivary cytokine measurement as a practical, non-invasive, and effective tool for monitoring the immunological status and recovery of COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Marques et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: